Furthermore, lnc-PKD2-2-3, miR-328, and GPAM were also observed to be linked with advanced tumor features such as differentiation and tumor stage in CCA patients, which result from regulation of tumor stemness, growth, and metastasis (19, 28–30). This evidence concerns the gene GPAM and cholangiocarcinoma.